Executive Director, Global Site & Study Operations, Americas
Amgen
September 12, 2026
Full-time
Remote friendly (United States)
Worldwide
Clinical Research and Development
Role: Executive Director, Global Site Study Operations, Americas, overseeing regional clinical trial portfolio across Phase I-IV in US, Canada, and LATAM. Objectives: deliver high-quality, compliant, timely clinical studies; shape site engagement and monitoring strategies; lead regional teams and influence global portfolio decisions. Responsibilities: manage regional study start-up, execution, and closeout; ensure inspection readiness; optimize resource deployment; implement innovative monitoring approaches; foster high-performing, inclusive teams; drive operational excellence, continuous improvement, and organizational change; build cross-functional partnerships; and represent the region in global governance.
Qualifications: Advanced degree (Bachelor's, Master’s, or Doctorate) with 6-15+ years in clinical research, including extensive leadership experience managing geographically dispersed teams and clinical trial portfolios. Demonstrated expertise in clinical operations, vendor governance, regulatory compliance, and study management across multiple phases. Knowledge of ICH-GCP, local regulations, and clinical quality systems is required.
High-Value Biopharma Details: Focus on Oncology, Inflammation, Rare Diseases, and General Medicine; experience with global/regional clinical trial execution; oversight of CRO/vendor relationships; and familiarity with clinical development across multiple phases. Leadership attributes include fostering a collaborative, inclusive, and innovative culture, with proven ability to lead organizational change and influence cross-functional stakeholders.
Qualifications: Advanced degree (Bachelor's, Master’s, or Doctorate) with 6-15+ years in clinical research, including extensive leadership experience managing geographically dispersed teams and clinical trial portfolios. Demonstrated expertise in clinical operations, vendor governance, regulatory compliance, and study management across multiple phases. Knowledge of ICH-GCP, local regulations, and clinical quality systems is required.
High-Value Biopharma Details: Focus on Oncology, Inflammation, Rare Diseases, and General Medicine; experience with global/regional clinical trial execution; oversight of CRO/vendor relationships; and familiarity with clinical development across multiple phases. Leadership attributes include fostering a collaborative, inclusive, and innovative culture, with proven ability to lead organizational change and influence cross-functional stakeholders.